Cost-benefit of vagus nerve stimulation for refractory epilepsy

Acta Neurologica Belgica

Volumn 99, Issue 4, 1999, Pages 275-280

  Boon, P ^a   Vonck, K ^a   D'Have, M ^a   O'Connor, S ^b   Vandekerckhove, T ^a   De Reuck, J ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Cyberonics Inc   (Italy)

Author keywords

Cost benefit analysis; Efficacy; Epilepsy surgery; Refractory epilepsy; Vagus nerve stimulation (VNS)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COST BENEFIT ANALYSIS; ELECTROSTIMULATION THERAPY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; TREATMENT OUTCOME; VAGUS NERVE;

ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; ELECTRIC STIMULATION THERAPY; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VAGUS NERVE;

EID: 0033251443     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BOON P., VONCK K., VANDEKERCKHOVE T., D'HAVÉ M., NIEUWENHUIS L., MICHIELSEN G., VANBELLEGHEM H., GOETHALS I., CAEMAERI J., CALLIAUW L., DE REUCK J. Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis. Acta Neurochirurgica, 1999, 141: 447-453.
2. BOON P. A., WILLIAMSON P. D. Presurgical evaluation of patients with partial epilepsy; indications and evaluation techniques for resective surgery. Clinical Neurology and Neurosurgery, 1989, 9: 3-11.
3. BRODIE M. J., RICHENS A., Yuen for the UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of Lamotrigin and Carbamazepine in newly diagnosed epilepsy. The Lancet, 1995, 345: 476-479.
4. FAUGHT E., WILDER B. J., RAMSAY R. E., REIFE R. A., KRAMER L. D. et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400 and 600 mg daily dosages. Neurology, 1996, 46: 1684-1690.
5. FISHER R. S. Emerging anti-epileptic drugs. Neurology, 1993, 43 (suppl. 5): 12-20.
6. GEORGE R., SALINSKY M., KUZNIECKY R., ROSENFIELD W., BERGEN D., TARVER W. B. et al. Vagus Nerve Stimulation for treatment of partial seizures: 3. Long-term follow-up on the first 67 patients exiting a controlled study. Epilepsia, 1994, 35: 637-643.
7. GEORGE R., SONNEN A., UPTON A. et al. The Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology, 1995, 45: 224-230.
8. HANDFORTH A., DEGORGIO C. M., SCHACHTER S. C., UTHMAN B. M., NARITOKU D. K., TECOMA E. S. et al. Vagus nerve stimulation therapy for partial onset seizures. A randomized active-control trial. Neurology, 1998, 51: 48-55.
9. HAUSER W. A., HESDORFFER D. H. In: Epilepsy: frequency, causes and consequences. New York: Demos, 1990, 1-51.
10. HENRY T. R., VOTAW J. R., PENNEL P. B. et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy. Neurology, 1999, 52: 1166-1173.
11. HORNIG G. W., MURPHY J. V., SCHALLERT G., TILTON C. Left vagus nerve stimulation in children with refractory epilepsy: an update. South Medical Journal, 1997, 90: 484-488.
12. KO D., HECK C., GRAFTON S. et al. Vagus nerve stimulation activates central nervous sytem structures in epileptic patients during PET H2 15O blood flow imaging. Neurosurgery, 1996, 39: 426-431.
13. KRAHL S. E., CLARK K. B., SMITH D. C., BROWNING R. A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia, 1998, 39 (7): 709-714.
14. LANDY H. J., RAMSAY R. E., SLATER J., CASIANO R. R., MORGAN R. Vagus nerve stimulation for complex partial seizures: surgical technique, safety and efficacy. Journal of Neurosurgery, 1993, 78: 26-31.
15. LUNDGREN J., AMARK P., BLENNOW G., STROMBLAD L. G., WALLSTEDT L. Vagus nerve stimulation in 16 children with refractory epilepsy. Epilepsia, 1998, 39: 809-813.
16. MCLACHLAN R. S. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia, 1993, 34: 918-923.
17. MURPHY J. V. and the pediatric VNS study group: Left vagal nerve stimulation in children with medically refractory epilepsy. Pediatrics, 1999, 134: 563-566.
18. MURRAY M. I., HALPERN M. T., LEPPIK I. E. Cost of refractory epilepsy in adults in the USA. Epilepsy Research, 1996, 23 (2): 139-48.
19. NARITOKU D. K. Vagus nerve stimulation: mechanisms of action. Epilepsia, 1998, 39 (2): 12.
20. NIH Consensus Development Conference. Surgery for epilepsy. US Department of Health and Human services, National Institutes of Health, Bethesda, Maryland 1990, 8: 1-20.
21. RAMSAY R. E., UTHMAN B. M., AUGUSTINSSON L. E., UPTON A. R. M., NARITOKU D., WILLIS J. et al. Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability. Epilepsia, 1994, 35 (3): 627-636.
22. REID S. A. Surgical technique for the implantation of the neurocybernetic prosthesis. Epilepsia, 1990, 31 (suppl. 2): 38-39.
23. SALINSKY M. C., UTHMAN B. M., RISTANOVIC R. K. et al. Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Archives of Neurology, 1996, 53: 1176-1180.
24. o 5. Gabapentin as add-on therapy in refractory parial epilepsy: a double-blind placebo-controlled, parallel group study. Neurology, 1993, 43: 2292-2298.
25. VONCK K., BOON P., D'HAVÉ M., VANDEKERCKHOVE T., O'CONNOR S., DE REUCK J. Long-term results of vagus nerve stimulation in refractory epilepsy. Seizure, 1999 (in press).
26. ZABARA J. Inhibition of experimental seizures in canines by repetetive vagal stimulation. Epilepsia, 1992, 33: 1005-1012.